OPXA Financial Facts
General and administrative: 512.73KNet loss: -2.01M
See Full Income Statement
Total assets: 7.18M
Other current assets: 224.81K
See Full Balance Sheet
Opexa Therapeutics, Inc. (OPXA) Earnings
|
Expand Research on OPXA
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -4.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -0.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/14/16 | Q316 | -$0.28 | -$0.25 | -$0.03 | $726.3K | $720K | N/A |  | | Details | |
8/11/16  |
 |
Q216 | -$0.30 | -$0.23 | -$0.07 | N/A | $720K | N/A | | | Details |
| 5/12/16 |
|
Q116 | -$0.31 | -$0.35 | +$0.04 | $726.3K | $400K | N/A | | | Details |
| 3/15/16 |
|
Q415 | N/A | -$0.50 | N/A | N/A | $720K | N/A | N/A | N/A | |
| 11/10/15 |
|
Q315 | -$0.42 | N/A | N/A | $726K | $307K | N/A | | | Details |
| 8/12/15 |
|
Q215 | -$0.07 | -$0.08 | +$0.01 | N/A | N/A | N/A | | | Details |
| 11/30/-1 |
|
Q115 | N/A | -$0.15 | N/A | N/A | $310K | N/A | N/A | N/A | |
| 8/14/14 | Q214 | -$0.15 | -$0.13 | -$0.02 | $307.7K | $330K | N/A | | | Details |
